Trademark: 79310050
Status Date
Tuesday, August 23, 2022
Registration Number
6823016
Registration Date
Tuesday, August 23, 2022
Filing Date
Friday, February 26, 2021
Published for Opposition
Tuesday, June 7, 2022
5 Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
Dec 23, 2023
Change Of Name/Address Rec'd From Ib
Dec 28, 2022
Final Decision Transaction Processed By Ib
Dec 1, 2022
Final Disposition Notice Sent To Ib
Dec 1, 2022
Final Disposition Processed
Nov 23, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 26, 2022
Change Of Name/Address Rec'd From Ib
Aug 23, 2022
Notice Of Registration Confirmation Emailed
Aug 23, 2022
Registered-Principal Register
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
Apr 29, 2022
Electronic Record Review Complete
Apr 1, 2022
On Hold - Electronic Record Review Required
Mar 27, 2022
Assigned To Lie
Mar 25, 2022
Approved For Pub - Principal Register
Mar 24, 2022
Teas/Email Correspondence Entered
Mar 24, 2022
Correspondence Received In Law Office
Mar 24, 2022
Teas Response To Office Action Received
Oct 25, 2021
Refusal Processed By Ib
Oct 9, 2021
New Representative At Ib Received
Sep 28, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Sep 28, 2021
Refusal Processed By Mpu
Sep 11, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 10, 2021
Non-Final Action Written
Sep 9, 2021
Assigned To Examiner
Aug 13, 2021
Change Of Owner Received From Ib
May 14, 2021
Application Filing Receipt Mailed
May 10, 2021
New Application Office Supplied Data Entered
May 8, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
